Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents
NCT00271258
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
SODIUM DIVALPROATE
Sponsor
Sanofi